1  retrograde cholangiopancreatography and the secretin test.

2 onths, and yearly for cure (fasting gastrin, secretin test. and imaging studies).

3 f 9 (55%) patients of group 2 had a negative secretin test at hospital discharge.

4 th the criteria developed, the intraarterial secretin test had high specificity but low sensitivity.

5 sessment of disease status (fasting gastrin, secretin test imaging within 2 weeks, at 3 to 6 months,

6  abdominal angiography, and an intraarterial secretin test, in which venous blood is sampled periodic

7  unless a hormone stimulation test such as a secretin test is performed.

8                                Intraarterial secretin test results assisted in clinical management in

9             Sensitivity of the intraarterial secretin test was 41%; of CT and ultrasound, 64%; and of